Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Alzheimer’s disease (AD) Dementia Late-onset Alzheimer’s disease (LOAD) Neuropsychiatric Inventory–Questionnaire (NPI-Q) Neuropsychiatric symptoms (NPS) Young-onset Alzheimer’s disease (YOAD)

Journal

GeroScience
ISSN: 2509-2723
Titre abrégé: Geroscience
Pays: Switzerland
ID NLM: 101686284

Informations de publication

Date de publication:
02 2021
Historique:
received: 10 09 2020
accepted: 18 11 2020
pubmed: 10 1 2021
medline: 1 6 2021
entrez: 9 1 2021
Statut: ppublish

Résumé

Young-onset and late-onset Alzheimer's disease has different clinical presentations with late-onset presenting most often with memory deficits while young-onset often presents with a non-amnestic syndrome. However, it is unknown whether there are differences in presentation and progression of neuropsychiatric symptoms in young- versus late-onset Alzheimer's disease. We aimed to investigate differences in the prevalence and severity of neuropsychiatric symptoms in patients with young- and late-onset Alzheimer's disease longitudinally with and without accounting for the effect of medication usage. Sex differences were also considered in these patient groups. We included 126 young-onset and 505 late-onset Alzheimer's disease patients from National Alzheimer's Coordinating Center-Uniform Data Set (NACC-UDS) and Alzheimer's Disease Neuroimaging Initiative (ADNI). We investigated the prevalence and severity of neuropsychiatric symptoms using the Neuropsychiatric Inventory-Questionnaire over 4 visits with 1-year intervals, using a linear mixed-effects model. The prevalence of depression was significantly higher in young-onset than late-onset Alzheimer's disease over a 4-year interval when antidepressant usage was included in our analyses. Our findings suggest that neuropsychiatric symptom profiles of young- and late-onset Alzheimer's disease differ cross-sectionally but also display significant differences in progression.

Identifiants

pubmed: 33420706
doi: 10.1007/s11357-020-00304-y
pii: 10.1007/s11357-020-00304-y
pmc: PMC8050126
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-223

Subventions

Organisme : NIA NIH HHS
ID : P30 AG049638
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016573
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG019610
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010161
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062428
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG035982
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG032438
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG053760
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066444
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010129
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062429
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG072122
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010124
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010133
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005146
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG016976
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005136
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG003991
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005681
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047266
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG026276
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG012300
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008051
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028383
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG008702
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047270
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005138
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008017
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047366
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG025688
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013846
Pays : United States

Références

Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017.
Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–17.
pubmed: 26921134
Eriksson H, Fereshtehnejad S-M, Falahati F, Farahmand B, Religa D, Eriksdotter M. Differences in routine clinical practice between early and late onset Alzheimer’s disease: data from the Swedish Dementia Registry (SveDem). J Alzheimers Dis JAD. 2014;41(2):411–9.
pubmed: 24614905
Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2005;76(1):112–4.
pubmed: 15608008 pmcid: 1739332
Sakai M, Hanyu H, Kume K, Sato T, Hirao K, Kanetaka H, et al. Rate of progression of Alzheimer’s disease in younger versus older patients: a longitudinal single photon emission computed tomography study. Geriatr Gerontol Int. 2013;13(3):555–62.
pubmed: 22963387
Nochlin D, van Belle G, Bird TD, Sumi SM. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1993;7(4):212–22.
pubmed: 8305189
Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer’s disease: a CERAD analysis, Part XII. Neurology. 1996;46(1):136–41.
pubmed: 8559362
Seltzer B, Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? Arch Neurol. 1983;40(3):143–6.
pubmed: 6830452
Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, et al. Age at onset of Alzheimer’s disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994;44(7):1215–20.
pubmed: 8035918
Katzman R. Alzheimer’s disease as an age-dependent disorder. CIBA Found Symp. 1988;134:69–85.
pubmed: 2896109
Bowler JV, Munoz DG, Merskey H, Hachinski V. Factors affecting the age of onset and rate of progression of Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1998;65(2):184–90.
pubmed: 9703168 pmcid: 2170212
Panegyres PK, Chen H-Y. Differences between early and late onset Alzheimer’s disease. Am J Neurodegener Dis. 2013;2(4):300–6.
pubmed: 24319647 pmcid: 3852569
Toyota Y, Ikeda M, Shinagawa S, Matsumoto T, Matsumoto N, Hokoishi K, et al. Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22(9):896–901.
pubmed: 17343292
Ferran J, Wilson K, Doran M, Ghadiali E, Johnson F, Cooper P, et al. The early onset dementias: a study of clinical characteristics and service use. Int J Geriatr Psychiatry. 1996;11(10):863–9.
Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, et al. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer’s Disease Consortium (EADC) study. Acta Clin Belg. 2007;62(6):426–32.
pubmed: 18351187
Smits LL, Pijnenburg YAL, Koedam ELGE, van der Vlies AE, Reuling IEW, Koene T, et al. Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis JAD. 2012;30(1):101–8.
pubmed: 22366769
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288(12):1475–83.
pubmed: 12243634
Kiely KM, Mortby ME, Anstey KJ. Differential associations between sensory loss and neuropsychiatric symptoms in adults with and without a neurocognitive disorder. Int Psychogeriatr. 2018;30(2):261–72.
pubmed: 28724467
Cuijpers P. Depressive disorders in caregivers of dementia patients: a systematic review. Aging Ment Health. 2005;9(4):325–30.
pubmed: 16019288
de Vugt ME, Nicolson NA, Aalten P, Lousberg R, Jolle J, Verhey FRJ. Behavioral problems in dementia patients and salivary cortisol patterns in caregivers. J Neuropsychiatry Clin Neurosci. 2005;17(2):201–7.
pubmed: 15939974
Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry. 2015;172(5):460–5.
pubmed: 25585033 pmcid: 4416978
González-Salvador MT, Arango C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry. 1999;14(9):701–10.
pubmed: 10479740
Chiao C-Y, Wu H-S, Hsiao C-Y. Caregiver burden for informal caregivers of patients with dementia: a systematic review. Int Nurs Rev. 2015;62(3):340–50.
pubmed: 26058542
Bature F, Guinn B, Pang D, Pappas Y. Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open. 2017;7(8):e015746.
pubmed: 28851777 pmcid: 5724073
Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(2):126–33.
pubmed: 21382304 pmcid: 3076589
Reed J, Cantley C, Clarke CL, Stanley D. Services for younger people with dementia: problems with differentiating needs on the basis of age. Dementia. 2002;1(1):95–112.
Rosness TA, Barca ML, Engedal K. Occurrence of depression and its correlates in early onset dementia patients. Int J Geriatr Psychiatry. 2010;25(7):704–11.
pubmed: 20069586
van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YAL, Vernooij-Dassen MJFJ, et al. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer’s disease - part 1: findings of the two-year longitudinal NeedYD-study. Dement Geriatr Cogn Disord. 2012;34(5–6):319–27.
pubmed: 23208452
Porter VR, Buxton WG, Fairbanks LA, Strickland T, O’Connor SM, Rosenberg-Thompson S, et al. Frequency and characteristics of anxiety among patients with Alzheimer’s disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003;15(2):180–6.
pubmed: 12724459
Lawlor BA, Ryan TM, Schmeidler J, Mohs RC, Davis KL. Clinical symptoms associated with age at onset in Alzheimer’s disease. Am J Psychiatry. 1994;151(11):1646–9.
pubmed: 7943455
Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, et al. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set. Alzheimer Dis Assoc Disord. 2018;32(4):351–8.
pubmed: 30376508 pmcid: 6249084
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14.
pubmed: 7991117
Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–4.
pubmed: 8232972
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2018. Available from: https://www.R-project.org/
Makowski D. The psycho package: an efficient and publishing-oriented workflow for psychological science. J Open Source Softw. 2018;3(22):470.
Kaiser NC, Liang L-J, Melrose RJ, Wilkins SS, Sultzer DL, Mendez MF. Differences in anxiety among patients with early- versus late-onset Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 2014;26(1):73–80.
pubmed: 24515678
Panegyres PK, Chen HY. Early-onset Alzheimer’s disease: a global cross-sectional analysis. Eur J Neurol. 2014;21(9):1149–e65.
pubmed: 24780092
Zhao Q-F, Tan L, Wang H-F, Jiang T, Tan M-S, Tan L, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–71.
pubmed: 26540080
Ferreira M d C, Abreu MJ, Machado C, Santos B, Machado Á, Costa AS. Neuropsychiatric profile in early versus late onset Alzheimer’s disease. Am J Alzheimers Dis Other Dement. 2018;33(2):93–9.
Hori K, Oda T, Asaoka T, Yoshida M, Watanabe S, Oyamada R, et al. First episodes of behavioral symptoms in Alzheimer’s disease patients at age 90 and over, and early-onset Alzheimer’s disease: comparison with senile dementia of Alzheimer’s type. Psychiatry Clin Neurosci. 2005;59(6):730–5.
pubmed: 16401251
Svanberg E, Spector A, Stott J. The impact of young onset dementia on the family: a literature review. Int Psychogeriatr. 2011;23(3):356–71.
pubmed: 20735892
Mendez MF. Early-onset Alzheimer’s disease: nonamnestic subtypes and type 2 AD. Arch Med Res. 2012;43(8):677–85.
pubmed: 23178565 pmcid: 3532551
Calleo J, Kunik ME, Reid D, Kraus-Schuman C, Paukert A, Regev T, et al. Characteristics of generalized anxiety disorder in patients with dementia. Am J Alzheimers Dis Other Dement. 2011;26(6):492–7.
Kuruppu DK, Matthews BR. Young-Onset Dementia. Semin Neurol. 2013;33(4):365–85.
pubmed: 24234358 pmcid: 4033406

Auteurs

Melisa Gumus (M)

Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Ave., Toronto, ON, M5T 2S8, Canada.

Namita Multani (N)

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Ave., Toronto, ON, M5T 2S8, Canada.

Michael L Mack (ML)

Department of Psychology, Faculty of Arts and Science, University of Toronto, Sidney Smith Hall, 100 St. George Street, Toronto, ON, M5S 3G3, Canada.

Maria Carmela Tartaglia (MC)

Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. carmela.tartaglia@uhn.ca.
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Ave., Toronto, ON, M5T 2S8, Canada. carmela.tartaglia@uhn.ca.
Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St., Toronto, ON, M5T 2S8, Canada. carmela.tartaglia@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH